AMRA Medical AB

Based in Sweden, AMRA Medical AB, operates as a provider of MRI-based body composition analysis for research and patient care. Based in Linkoping, Sweden and founded in 2010, AMRA Medical AB provides advanced medical imaging services. The company specializes in MRI-based technologies that deliver precise fat and muscle analysis. In September 2026, AMRA Medical AB raised an undisclosed amount of venture funding from new investor HealthCap.

AMRA Medical specializes in advanced medical imaging services, particularly through its proprietary MRI-based technologies that deliver precise fat and muscle analysis. Their core offerings include the AMRA® Profiler 4, a medical device that provides detailed insights into individual patient body composition, and the AMRA® Researcher platform, which supports research biomarkers to enhance clinical trials and decision-making processes. AMRA serves a diverse client base including researchers, clinicians, pharmaceutical companies, and healthcare institutions, with a focus on the European and North American markets. AMRA Medical generates revenue primarily through subscriptions and partnerships with healthcare providers and research institutions.

Transactions typically take place through the licensing of their patented technology, alongside the provision of their imaging services for clinical and research applications. By engaging institutions in long-term partnerships, AMRA establishes a sustainable revenue stream that supports both service delivery and continuous innovation. The company will use the funding to support research and development, develop new MRI analysis products, and expand its operations in international markets.